Determining the Clinical Utility of Using Virtual Reality Headsets to Assess Visual Function in Those With Glaucoma.
Launched by QUEEN'S UNIVERSITY, BELFAST · Feb 13, 2020
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
Perimetry (or visual field testing) is a vision test used to evaluate a patient's peripheral vision. It involves a patient fixating on a central target and pressing a button when they see a spot of light in their peripheral vision. It is an important way of deciding whether Glaucoma is progressing or not. Next generation virtual reality (VR) technologies offer an exciting new way of conducting perimetry in either a clinical or home environment, allowing more affordable and more frequent monitoring of disease progression in glaucoma, and an easier and more comfortable experience for patients...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Patients with a clinical diagnosis of glaucoma with repeatable defects on standard automated perimetry.
- Exclusion Criteria:
- • Presence of other ocular disease which impacts vision such as age-related macular degeneration or diabetic retinopathy.
- • Any physical limitation that would make the participant unable to place their head in the head-rest to perform Humphrey Perimetry (Eg some patients with arthritic or neck problems are unable to use the headrests of ophthalmic devices).
- • Any cognitive impairment that would limit their ability to perform perimetry or a history of vertigo/dizziness.
About Queen's University, Belfast
Queen's University Belfast is a prestigious research institution located in Northern Ireland, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. The university actively engages in a diverse range of clinical trials, focusing on translational medicine and interdisciplinary collaboration to address pressing health challenges. With a strong emphasis on ethical standards and patient safety, Queen's University Belfast leverages its state-of-the-art facilities and a team of experienced researchers to contribute to the development of new therapies and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belfast, Northern Ireland, United Kingdom
Patients applied
Trial Officials
Ruth E Hogg, PhD
Principal Investigator
Queen's University, Belfast
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials